Proposal #668
Passed on 07 Jul 2026 with 63.0% of the votes for yes.
Yes
63.0%
99.6% without abstain
Veto
0.0%
of votes cast
Ended
07 Jul 2026
63.03%
of votes cast
36.69%
of votes cast
0.28%
of votes cast
0.00%
of votes cast
If passed, this proposal will decrease the hourly funding rate caps for the ABNB/USDC PERP, ADBE/USDC PERP, AFRM/USDC PERP, AI/USDC PERP, AMC/USDC PERP, AMD/USDC PERP, AMGN/USDC PERP, ASML/USDC PERP, AVGO/USDC PERP, AXP/USDC PERP, BABA/USDC PERP, BAC/USDC PERP, BIDU/USDC PERP, BLK/USDC PERP, BX/USDC PERP, BYND/USDC PERP, C/USDC PERP, CHTR/USDC PERP, CME/USDC PERP, CMG/USDC PERP, COST/USDC PERP, CRM/USDC PERP, CRWD/USDC PERP, DELL/USDC PERP, DIS/USDC PERP, DKNG/USDC PERP, ENPH/USDC PERP, FLUT/USDC PERP, FSLR/USDC PERP, GILD/USDC PERP, GME/USDC PERP, GRAB/USDC PERP, GS/USDC PERP, HIMS/USDC PERP, INTC/USDC PERP, ISRG/USDC PERP, JD/USDC PERP, JPM/USDC PERP, KKR/USDC PERP, LLY/USDC PERP, LULU/USDC PERP, and LVS/USDC PERP markets to 0.00275%, and decrease the hourly funding rate cap for the GLXY/USDC PERP market to 0.0055%.
This proposal updates only the hourly funding rate cap parameter for the listed equity perpetual markets. All other market parameters will remain unchanged. This proposal is one of two waves for the broader equity funding cap update set.
Actions:
Disclosure: I am a member of the Injective Labs team.